知镜 Cognispect · 医学文献与研究工作台

Ameliorative effects of Chlorophytum borivilianum on atopic dermatitis via modulation of inflammatory biomarkers and GC-MS-based metabolite profiling.

Razzaq B, Jameel S, Asif A, Shaheryar ZA, Shafeeq Ur Rehman M, Al-Qaaneh AM.
Molecular biology reports · 2026-05-13 · PMID 42126771

文献摘要

Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by pruritus, xerosis, and immune dysregulation. Current therapies are often associated with adverse effects and limited long-term compliance. Chlorophytum borivilianum possesses documented anti-inflammatory, antioxidant, and immunomodulatory properties [1]. This study aims to investigate the therapeutic effects of C. borivilianum root extract (CPEx) and dichloromethane fraction (DCMF) in a 2,4-dinitrochlorobenzene (DNCB)-induced Swiss albino mouse model GC-MS analysis identified critical bioactive metabolites, including (6)-shogaol, piperine, and polyunsaturated fatty acids. Topical administration of 4% CPEx and 4% DCMF significantly improved clinical dermatitis scores and reduced epidermal hyperplasia. These improvements were accompanied by significant downregulation of pro-inflammatory cytokine gene expressions (IL-4, IL-6, IL-13, TNF-α). Furthermore, treatment significantly reduced serum IgE levels and restored redox balance by increasing superoxide dismutase (SOD) and catalase (CAT) activities while decreasing malondialdehyde (MDA) and nitric oxide (NO) levels.Histopathological evaluation confirmed the restoration of skin barrier integrity and the reduction of inflammatory cell infiltration. Our results suggest that C. borivilianum exerts potent anti-inflammatory and antioxidant effects through the modulation of the Th2 axis and Nrf2-mediated pathways, establishing its potential as a safe and effective natural candidate for the management of atopic dermatitis.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。